Vertex Pharmaceuticals Incorporated (VRTX)
NASDAQ: VRTX · Real-Time Price · USD
546.12
-11.84 (-2.12%)
At close: Sep 4, 2026, 4:00 PM EDT
545.00
-1.12 (-0.21%)
After-hours: Sep 4, 2026, 7:57 PM EDT
Vertex Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citi | Citi | Buy Maintains $585 | Buy | Maintains | $585 | +7.12% | Sep 2, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $665 | Buy | Initiates | $665 | +21.77% | Sep 2, 2026 |
| UBS | UBS | Buy Reiterates $585 | Buy | Reiterates | $585 | +7.12% | Aug 20, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $600 | Buy | Maintains | $600 | +9.87% | Aug 18, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $570 | Buy | Maintains | $570 | +4.37% | Aug 12, 2026 |
| Jefferies | Jefferies | Buy Maintains $610 → $633 | Buy | Maintains | $610 → $633 | +15.91% | Aug 11, 2026 |
| Bernstein | Bernstein | Buy Maintains $608 | Buy | Maintains | $608 | +11.33% | Aug 11, 2026 |
| Scotiabank | Scotiabank | Buy Maintains $558 | Buy | Maintains | $558 | +2.18% | Aug 11, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.